Portable MRI and NMR machines firm Nanalysis Scientific Corp (OTCMKTS:NSCIF) has been in considerable focus among investors over the course of the past month and during that period, the stock has managed to clock gains of as much as 32%.
The company, which primarily provides its machines for industrial applications and healthcare, announced its preliminary revenues numbers for the fiscal second quarter last week and the numbers were strong. Nanalysis announced preliminary revenues to the tune of $4.4 million, which reflects a year on year rise of as much as 120% from the revenues in the prior year period.
While the company is not going to release its financial results up until mid-August, Nanalysis decided to announce the preliminary revenues in order to reveal the sort of growth that it has recorded in recent times. Luke Caplette, who is the Chief Financial Officer of the company, spoke about this decision as well.
He stated that in addition to highlighting the growth generated by the company, the preliminary revenue announcement also shows that Nanalysis’ fundamentals are also being strengthened. Considering the gains made by the company, it is likely that investors are going to be waiting for the company’s full financial results quite keenly.
Market Reaction:
On Friday, NSCIF stock gained 1% at $1.0811 with more than 281K shares, compared to its average volume of 124k shares. The stock had moved within a range of $1.0500 – 1.1200 after opening the trade at $1.08. Over the past 52-week, the stock has been trading within a range of $0.3089 – 1.2100.